Owlet reports Q3 revenue of $17.4M; files two FDA applications for infant monitoring devices

Owlet, Inc.

2022-Q3 EPS reported -$0.54 revenue$57,246,000

Revenue of approximately $17.4 million for the third quarter of 2022.
Submitted 510(k) premarket notification to FDA for a new prescription monitoring device for infants.
Planned submission to FDA in coming weeks for SaaS medical device to add opportunistic notifications to Dream Sock.
Expanded retail footprint by adding ~1,200 new Walmart locations and product offering to ~600 Target locations.
Launched HD nursery Owlet Cam 2 and Predictive Sleep Technology tool in July.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Owlet, Inc. reported the fiscal quarter ended September 30, 2022 results: revenue approximately $17.4 million.

Period: the fiscal quarter ended September 30, 2022
Revenue: approximately $17.4 million
Result: reported results

Exact text from the filing

Generated revenues of approximately $17.4 million in the third quarter of 2022

View on SEC.gov

Browse all earnings releases →

Owlet, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-22-029831

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.